Solid Net Income Applicable To Common Shares from 2010 to 2024

SLDB Stock  USD 8.95  0.35  3.76%   
Solid Biosciences' Net Loss is decreasing over the years with slightly volatile fluctuation. Net Loss is expected to dwindle to about -81.3 M. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2015-12-31
Previous Quarter
-30.1 M
Current Value
-24.6 M
Quarterly Volatility
13.3 M
 
Yuan Drop
 
Covid
Check Solid Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Solid main balance sheet or income statement drivers, such as Interest Income of 7.4 M, Selling General Administrative of 20.8 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 10.66, Dividend Yield of 0.0 or PTB Ratio of 1.01. Solid financial statements analysis is a perfect complement when working with Solid Biosciences Valuation or Volatility modules.
  
This module can also supplement Solid Biosciences' financial leverage analysis and stock options assessment as well as various Solid Biosciences Technical models . Check out the analysis of Solid Biosciences Correlation against competitors.

Latest Solid Biosciences' Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Solid Biosciences LLC over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Solid Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Solid Biosciences' overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Solid Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(46,155,463)
Coefficient Of Variation(86.78)
Mean Deviation36,536,894
Median(39,317,000)
Standard Deviation40,055,293
Sample Variance1604.4T
Range110.8M
R-Value(0.85)
Mean Square Error476.1T
R-Squared0.72
Significance0.000057
Slope(7,623,528)
Total Sum of Squares22462T

Solid Net Income Applicable To Common Shares History

2024-81.3 M
2023-77.4 M
2022-86 M
2021-72.2 M
2020-88.3 M
2019-117.2 M
2018-74.8 M

About Solid Biosciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Solid Biosciences income statement, its balance sheet, and the statement of cash flows. Solid Biosciences investors use historical funamental indicators, such as Solid Biosciences's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Solid Biosciences investors may use each financial statement separately, they are all related. The changes in Solid Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Solid Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Solid Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Solid Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-77.4 M-81.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:
Check out the analysis of Solid Biosciences Correlation against competitors.
Note that the Solid Biosciences LLC information on this page should be used as a complementary analysis to other Solid Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Solid Stock analysis

When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Solid Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.83)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.57)
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.